The influence of light at night exposure on melatonin levels among Canadian rotating shift nurses

Cancer Epidemiology Biomarkers and Prevention

Volumn 20, Issue 11, 2011, Pages 2404-2412

  Grundy, Anne ^a,b   Tranmer, Joan ^a   Richardson, Harriet ^a,b   Graham, Charles H ^a   Aronson, Kristan J ^a,b  

^a QUEEN S UNIVERSITY   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MELATONIN;

ARTICLE; CANADA; FEMALE; HUMAN; LIGHT EXPOSURE; MULTIVARIATE ANALYSIS; NURSE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; SALIVA; SHIFT WORKER; SUMMER; WINTER;

ADULT; CANADA; CIRCADIAN RHYTHM; FEMALE; HUMANS; LIGHT; MELATONIN; NURSES; RISK FACTORS; SALIVA; TIME FACTORS; WORK SCHEDULE TOLERANCE;

EID: 81155123718     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-11-0427     Document Type: Article

References (52)

1. Davis S, Mirick DK, Stevens RG. Night shift work, light at night and risk of breast cancer. J Natl Cancer Inst 2001;93:1563-8.
2. Lie J-AS, Roessink J, Kjaerheim K. Breast cancer and night work among Norwegian nurses. Cancer Causes Control 2006;17:39-44. (Pubitemid 43083668)
3. Schernhammer ES, Laden F, Speizer RE, Willet WC, Hunter DJ, Kawachi I, et al. Rotating night shifts and risk of breast cancer in women participating in the Nurses Health Study. J Natl Cancer Inst 2001;93:1563-8. (Pubitemid 32998486)
4. Schernhammer ES, Kroenke CH, Laden F, Hankinson SE. Night work and risk of breast cancer. Epidemiology 2006;17:108-11.
5. Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, Kawachi I, et al. Night shift work and risk of colorectal cancer in the nurses health study. J Natl Cancer Inst 2006;95:825-8.
6. Conlon M, Lightfoot N, Kreiger N. Rotating shift work and risk of prostate cancer. Epidemiology 2007;18:182-3. (Pubitemid 46005923)
7. Kubo T, Ozasa K, Mikami K, Wakai K, Fujino Y, Watanabe Y, et al. Prospective cohort study of the risk of prostate cancer among rotation-shift workers: findings from the Japan collaborative cohort study. Am J Epidemiol 2006;164:549-55. (Pubitemid 44412783)
8. Viswanathan AN, Hankinson SE, Schernhammer ES. Night shift work and the risk of endometrial cancer. Cancer Res 2007;67:10618-22. (Pubitemid 350070839)
9. Schwartzbaum J, Ahlbom A, Feychting M. Cohort study of cancer risk among male and female shift workers. Scand J Work Environ Health 2007;33:336-43. (Pubitemid 350186761)
10. O'Leary ES, Schoenfeld ER, Stevens RG, Kabat GC, Henderson K, Grimson R, et al. Shift work, light at night, and breast cancer on Long Island, New York. Am J Epidemiol 2006;164:358-66. (Pubitemid 44297344)
11. Pesch B, Harth V, Rabstein S, Baisch C, Schiffermann M, Pallapies D, et al. Night work and breast cancer-results from the German GENICA study. Scand J Work Environ Health 2010;36:134-41.
12. Pronk A, Ji BT, Shu XO, Xue S, Yang G, Li HL, et al. Night-shift work and breast cancer risk in a cohort of Chinese women. Am J Epidemiol 2010;171:953-9.
13. Straif K, Baan R, Grosse Y, Secretan B, El Ghissassi F, Bouvard V, et al. Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol 2007;8:1065-6.
14. Megdal SP, Kroenke CH, Laden F, Pukkala E, Schernhammer ES. Night work and breast cancer risk: a systematic review and metaanalysis. Eur J Cancer 2005;41:2023-32. (Pubitemid 41557687)
15. Erren TC, Paper HG, Reiter RJ, Piekarski C. Chronodisruption and cancer. Nautrwissenschaften 2008;95:367-82.
16. Haus E. Circadian disruption in shiftwork is probably carcinogenic to humans. Chronobiol Int 2008;24:1255-6.
17. Vijayalaxmi V, Thomas CR, Reiter RJ, Herman TS. Melatonin: From basic research to cancer treatment clinics. J Clin Oncol 2002;20:2575-601. (Pubitemid 34525746)
18. Stevens RG. Electric power use and breast cancer: A hypothesis. Am J Epidemiol 1987;125:556-61. (Pubitemid 17047129)
19. Davis S, Mirick DK. Circadian disruption, shift work and the risk of cancer: a summary of the evidence and studies in Seattle. Cancer Causes Control 2006;17:539-45.
20. Anisimov VN, Popovich IG, Zabezhiniski MA. Melatonin and colon carcinogenesis: I. Inhibitory effect of melatonin on development of intestinal tumors induced by 1,2-dimethylhydrazine in rats. Carcinogenesis 1997;18:1549-53. (Pubitemid 28134778)
21. Blask DE, Brainard GC, Dauchy RT, Hanifin JP, Davidson LK, Krause JA, et al. Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats. Cancer Res 2005;65:11174-84. (Pubitemid 41713389)
22. Cini G, Coronnello M, Mini E, Neri B. Melatonin's growth-inhibitory effect on hepatoma AH 130 in the rat. Cancer Lett 1998;125:51-9. (Pubitemid 28151909)
23. Tamarkin L, Cohen M, Roselle D, Reichert C, Lippman M, Chabner B. Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz(a) anthracene-induced mammary tumours in the rat. Cancer Res 1981;41:4432-6. (Pubitemid 12201353)
24. Cos S, Gonzalez A, Martinez-Campa C, Mediavilla MD, Alonso-Gonzalez C, Sanchez-Barcelo EJ. Estrogen signaling pathway: A link between breast cancer and melatonin oncostatic actions. Cancer Detect Prev 2006;30:118-28. (Pubitemid 43766230)
25. Reiter RJ. Mechanisms of cancer inhibition by melatonin. J Pineal Res 2004;37:213-4. (Pubitemid 39274120)
26. Schernhammer ES, Hankinson SE. Urinary melatonin levels and breast cancer risk. J Natl Cancer Inst 2005;97:1084-7. (Pubitemid 41417926)
27. Schernhammer ES, Berrrino F, Krogh V, Secreto G, Micheli A, Venturelli E, et al. Urinary 6-sulfatoxymelatonin levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 2008;100:898-905. (Pubitemid 351881952)
28. Schernhammer ES, Hankinson SE. Urinary melatonin levels and postmenopausal breast cancer risk in the Nurses' Health Study cohort. Cancer Epidemiol Biomarkers Prev 2009;18:74-9.
29. Travis RC, Allen DS, Fentiman IS, Key TJ. Melatonin and breast cancer: A prospective study. J Natl Cancer Inst 2004;96:475-82. (Pubitemid 38443651)
30. Schernhammer ES, Berrino F, Krogh V, Secreto G, Micheli A, Venturelli E, et al. Urinary 6-sulfatoxymelatonin levels and risk of breast cancer in premenopausal women: The ORDET cohort. Cancer Epidemiol Biomarkers Prev 2010;19:729-37.
31. Lewy AJ, Wehr TA, Goodwin FK, Newsome DA, Markey SP. Light suppresses melatonin secretion in humans. Science 1980;210:1267-9. (Pubitemid 11178017)
32. McIntyre IM, Norman TR, Burrows GD, Armstrong SM. Quantal melatonin suppression by exposure to low intensity light in man. Life Sci 1989;45:327-32. (Pubitemid 19196601)
33. Claustrat B, Brun J, Chazot G. The basic physiology and pathophysiology of melatonin. Sleep Med Rev 2005;9:11-24. (Pubitemid 40092915)
34. Trinder J, Armstrong SM, O'Brien C, Luke D, Martin MJ. Inhibition of melatonin secretion onset by low levels of illumination. J Sleep Res 1996;5:77-82. (Pubitemid 26235998)
35. Zeitzer JM, Dijk DJ, Kronauer RE, Brown EN, Czeixler CA. Sensitivity of the human circadian pacemaker to nocturnal light: melatonin phase resetting and suppression. J Physiol 2000;526:695-702. (Pubitemid 30654770)
36. Schernhammer ES, Rosner B, Willet WC, Laden F, Colditz GA, Hankinson SE. Epidemiology of urinary melatonin in women and its relation to other hormones and night work. Cancer Epidemiol Biomarkers Prev 2004;13:936-43. (Pubitemid 38756703)
37. Borougian MJ, Gallagher RP, Friesen MC, Switzer TF, Aronson KJ. Twenty-four-hour light exposure and melatonin levels among shift workers. J Occup Environ Med 2005;47:1268-75. (Pubitemid 41813035)
38. Hansen AM, Garde AH, Hansen J. Diurnal urinary 6-sulfatoxymelatonin levels among healthy Danish nurses during work and leisure time. Chronobiol Int 2006;23:1203-15. (Pubitemid 46033066)
39. Burch JB, Yost MG, Johnson W, Allen E. Melatonin, sleep and shift work adaptation. J Occup Environ Med 2005;47:893-901. (Pubitemid 41306701)
40. Grundy A, Sanchez M, Richardson H, Tranmer J, Borougian M, Graham CH, et al. Light intensity exposure, sleep duration, physical activity and biomarkers of melatonin among rotating shift nurses. Chronobiol Int 2009;26:1443-61.
41. Nagata C, Nagao Y, Yamamoto S, Shibuya C, Kashiki Y, Shimizu H. Light exposure at night, urinary 6-sulfatoxymelatonin, and serum estrogens and androgens in postmenopausal Japanese women. Cancer Epidemiol Biomarkers Prev 2008;17:1418-23.
42. Kantermann T, Juda M, Vetter C, Roenneberg T. Shift-work research: where do we stand, where should we go? Sleep Biol Rhythms 2010;8:95-105.
43. Stevens RG, Hansen J, Costa G, Haus E, Kauppinen T, Aronson KJ, et al. Considerations of circadian impact for defining shift work in cancer studies: IARC Working Group Report. Occup Environ Med 2011;68:154-62.
44. Horne JA, Ostberg O. A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms. Int J Chronobiol 1976;4:97-110. (Pubitemid 8001177)
45. Graham C, Cook MR, Kavet R, Sastre A, Smith DK. Prediction of nocturnal plasma melatonin from first morning urinary measures. J Pineal Res 1998;24:230-8. (Pubitemid 28206444)
46. Voultsious A, Kennaway DJ, Dawson D. Salivary melatonin as a circadian phase marker: validation and comparison to plasma melatonin. J Biol Rhythms 1997;12:457-66. (Pubitemid 127478560)
47. Greenland S, Rothman KJ. Introduction to stratified analysis. In: Rothman KJ, Greenland S. Modern Epidemiology, 2nd Edition. Philadelphia: Lippincott-Raven; 1998. p. 253-79.
48. Fritschi L, Glass DC, Heyworth JS, Aronson KJ, Girschik J, Boyle T, et al. Hypotheses for mechanisms linking shift work and cancer. Med Hypotheses 2011;77:430-6.
49. Schernhammer ES, Kroenke CH, Dowsett M, Folkerd E, Hankinson SE. Urinary 6-sulfatoxymelatonin levels and their correlations with lifestyle factors and steroid hormone levels. J Pineal Res 2006;40:116-24.
50. Ronneberg T, Kuehnle T, Juda M, Kantermann T, Allebrandt K, Gordijn M, et al. Epidemiology of the human circadian clock. Sleep Med Rev 2007;11:429-38. (Pubitemid 350087711)
51. Hrushesky WJ, Blask DE. Re: Melatonin and breast cancer: a prospective study. J Natl Cancer Inst 2004;96:888-9. (Pubitemid 38807614)
52. Fritschi L. Shift work and cancer. BMJ 2009;339:b2653.